It is defined by a lack of estrogen and progesterone hormone receptors (ER/PR) and expression of human epidermal growth factor receptor 2 (HER2), i.e., common treatment options are not very effective, resulting in a lower 5-year survival rate (77%) than other types of breast cancer (93%) [5,6]. Here, ERBB2 is linked to breast carcinoma.